Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Global Health EDCTP3 Joint Undertaking (EDCTP3)

Global collaboration action for the development of TB drugs for therapy and chemoprophylaxis in adults and children in sub-Saharan Africa

Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.

ClosedGlobal Health EDCTP3 Joint Undertaking (EDCTP3)EUAlbaniaArmeniaBosnia and HerzegovinaCanadaFaroe IslandsGeorgiaIcelandIsraelKosovoMoldovaMontenegroNew ZealandNorth MacedoniaNorwaySerbiaSouth KoreaSwitzerlandTunisiaTรผrkiyeUkraineUnited KingdomEgyptMoroccoBJBFBICMCICDEthiopiaSZGAGMGhanaGWGNKenyaLRMWMLMZNENigeriaCGRwandaSenegalSLSOSouth AfricaTanzaniaUgandaZMZW

This is a two-stage Research and Innovation Action run by Global Health EDCTP3. On the full second-stage application, each of the three award criteria -- Excellence, Impact, and Quality and Efficiency of the implementation -- is scored out of 5, with individual thresholds of 4, 4 and 3, and an overall threshold of 12 out of 15; proposals clearing every threshold are funded within budget, with a poโ€ฆ

This call wants clinical trials that push new or improved TB drugs, shorter treatment regimens, or chemoprophylaxis toward registration, including for multidrug- and extensively drug-resistant TB. It also welcomes proposals combining TB post-exposure prophylaxis with leprosy prevention, since the two diseases share transmission routes and drug candidates. Preclinical work, vaccines, diagnostics and monoclonal antibodies are out of scope.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.โ‚ฌ30M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Closed

Accelerating the Development of Prophylactic Vaccines Against Neglected Tropical Diseases (NTDs) in Sub-Saharan Africa

๐Ÿ‡ช๐Ÿ‡บEDCTP3 ยท European Union

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

MedtechBiotech
โ‚ฌ15.3M
Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Closed

Dr Pascoal Mocumbi Prize

๐Ÿ‡ช๐Ÿ‡บEDCTP3 ยท European Union

Awards EUR 50,000 to one scientist recognised for advancing clinical development of products for poverty-related diseases in Africa.

Medtech
โ‚ฌ50K
Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Closed

Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence

๐Ÿ‡ช๐Ÿ‡บEDCTP3 ยท European Union

Funds coordination projects that scale up validated digital health and AI tools across national or sub-regional health systems in sub-Saharan Africa.

MedtechAI
โ‚ฌ2.3M
Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Closed

Global Collaboration Action for Prevention and Treatment of Lower Respiratory Tract Infections (LRTIs) in Sub-Saharan Africa

๐Ÿ‡ช๐Ÿ‡บEDCTP3 ยท European Union

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

MedtechBiotech
โ‚ฌ8.5M
Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Closed

Global Collaboration Action for Research on Existing Malaria Therapeutics and Clinical Development of New Antimalarial Candidates

๐Ÿ‡ช๐Ÿ‡บEDCTP3 ยท European Union

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

MedtechBiotech
โ‚ฌ10.3M
Global Health EDCTP3 Joint Undertaking (EDCTP3) logo
Closed

Global Collaboration Action for Strengthening the Regional Networks of Excellence and Epidemic Preparedness Consortia

๐Ÿ‡ช๐Ÿ‡บEDCTP3 ยท European Union

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

MedtechBiotech
โ‚ฌ13.3M
European Commission logo
Scheduled

Clinical trials for advancing innovative interventions for neurodegenerative diseases

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.

MedtechBiotech
โ‚ฌ10MApr'27
Department for Science, Innovation and Technology logo
Open

Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

๐Ÿ‡ฌ๐Ÿ‡งDSIT ยท United Kingdom

Capital grants for large-scale UK life sciences R&D investments.

BiotechMedtech+1
ยฃ5M โ€“ ยฃ25MApr'28
European Commission logo
Scheduled

Mission Soil and Cancer: Living Labs for Carcinogenic Contamination

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds two โ‚ฌ12M projects using living labs to remediate carcinogenic soils and trace cancer risks through people, food, water and air.

Climate TechMedtech+2
โ‚ฌ12MSep'27
European Commission logo
Scheduled

Personalised approaches to reduce risks from adverse drug reactions due to multiple medications

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds safer medication management using biomarkers, clinical data and decision support.

MedtechBiotech+1
โ‚ฌ8M โ€“ โ‚ฌ10MApr'27
European Innovation Council logo
Open

EIC Accelerator Challenge: Biotech for Regenerating Agricultural Soils

๐Ÿ‡ช๐Ÿ‡บEIC ยท European Union

Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.

AgritechBiotech+3
โ‚ฌ1M โ€“ โ‚ฌ12.5MNov'26
European Commission logo
Scheduled

Horizon Health: Antibody Therapies for Emerging Viruses

๐Ÿ‡ช๐Ÿ‡บEuropean Commission ยท European Union

Funds โ‚ฌ9โ€“10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.

BiotechMedtech
โ‚ฌ9M โ€“ โ‚ฌ10MApr'27